Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: Implications for the growth and cellular invasion of the extracellular matrix

Journal of Neuro-Oncology

Volumn 28, Issue 1, 1996, Pages 13-24

  Nakagawa, Takao ^a   Kubota, Toshihiko ^a   Kabuto, Masanori ^a   Fujimoto, Noboru ^b   Okada, Yasunori ^c  

^a UNIVERSITY OF FUKUI   (Japan)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Extracellular matrix; Invasion; Malignant glioma; Matrix metalloproteinases

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGEN TYPE 5; FIBRONECTIN; GELATINASE; LAMININ; MATRIGEL; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL MOTILITY; CELL SECRETION; CELL STRAIN; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME RELEASE; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; STRAIN DIFFERENCE;

BRAIN NEOPLASMS; CELL DIVISION; CELL MOVEMENT; COLLAGEN; COLLAGENASES; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; GELATINASES; GLIOMA; GLYCOPROTEINS; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEASE INHIBITORS; PROTEINS; PROTEOGLYCANS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED;

EID: 0029932140     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00300442     Document Type: Article

References (47)

1. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336, 1991
2. Brown PD, Bloxidge RE, Stuart NSA, Gatter KC, Carmichael J: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 85: 574-578, 1993
3. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993
4. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F: Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5465-5369, 1993
5. Naylor MS, Stamp GW, Davies BD, Balkwill FR: Expression and activity of MMPs and their regulators in ovarian cancer. Int J Cancer 58: 50-56, 1994
6. Stearns ME, Wang M: Type IV collagenase (Mr 72,000) expression in human prostate: Benign and malignant tissue. Cancer Res 53: 878-883, 1993
7. Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ: Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322-2329, 1990
8. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y: Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69-77, 1994
9. Nakano A, Tani E, Miyazaki K, Furuyama J, Matsumoto T: Expression of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun 192: 999-1003, 1993
10. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R: Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208-2211, 1993
11. Rao JS, Steck PA, Tofilon P, Boyd D, Alim-Osman F, Stetler-Stevenson WG, Liotta LA, Sawaya R: Role of plasminogen activator and of 92-kDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neurooncol 18: 129-138, 1993
12. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S, Kuwano M: Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis 12: 296-304, 1994
13. Rutka JT, Matsuzawa K, Hubbard SL, Furuyama K, Becker LE, Stetler-Stevenson W, Edwards DR, Dirks PB: Expression of TIMP-1, TIMP-2, 72- and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with astrocytoma cell invasiveness. Int J Oncol 6: 877-884, 1995
14. Ohnishi T, Arita N, Hayakawa T, Kawahara K, Kato K, Kakimura A: Purification of motility factor (GMF) from human malignant glioma cells and its biological significance in tumor invasion. Biochem Biophys Res Commun 193: 518-525, 1993
15. Boone TC, Johnson MJ, DeClerck YA, Langley KE: cDNA cloning and expression of a metalloproteinase inhibitor re-lated to tissue inhibitor of metalloproteinase. Proc Natl Acad Sci USA 87: 2800-2804, 1990
16. Carmichael DF, Sommer A, Thompson RC, Anderson DC, Smith CG, Welgus HG, Stricklin GP: Primary structure and cDNA cloning of human fibloblast collagenase inhibitor. Proc Natl Acad Sci USA 83: 2407-2411, 1986
17. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987
18. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL: Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260: 2493-2500, 1985
19. Chin JR, Murphy G, Werb Z: Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase: Biosynthesis, isolation, characterization and substrates. J Biol Chem 260: 12367-12376, 1985
20. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979
21. Tanaka K, Iwamoto Y, Ito Y, Ishibashi T, Nakabeppu Y, Sekiguchi M, Sugioka Y: Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res 55: 2927-2935, 1995
22. Zhang J, Fujimoto N, Iwata K, Sakai T, Okada Y, Hayakawa T: A one-step sandwich immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies. Clin Chim Acta 219: 1-14, 1993
23. Fujimoto N, Hosokawa K, Iwata T, Shinya T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms human matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 231: 79-88, 1994
24. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 221: 91-103, 1993
25. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 220: 31-45, 1993
26. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 127: 103-108, 1990
27. Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, Shinmei M, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (strome-lysin-1) using monoclonal antibodies. Clin Chim Acta 211: 59-72, 1992
28. Morré DJ, Morré DM, Mollenhauser HH, Reutter W: Golgi apparatus cisternae of monensin-treated cells accumulate in the cytoplasm of liver slices. Eur J Cell Biol 43: 235-242, 1987
29. Tartakoff AM: Perturbation of vesicular traffic with carboxylic ionophore monensin. Cell 32: 1026-1028, 1983
30. Bernstein JJ, Laws ER, Levine KV, Wood LR, Tadvalkar G, Goldberg WJ: C6 glioma-astrocytoma cell and fetal astrocyte migration into artificial basement membrane: A permissive substrate for neural tumors but not fetal astrocytes. Neurosurgery 28: 652-658, 1991
31. Schlechte W, Brattain M, Boyd D: Invasion of extracellular matrix by cultured colon cancer: Dependence on receptor display. Cancer Commun 2: 173-179, 1990
32. Goldberg GI, Marmer BL, Grant AZ, Eisen AZ, Wilhelm S, He C: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 86: 8207-8211, 1989
33. Boghaert ER, Chan SK, Zimmer C, Grobelny D, Galardy RE, Vanaman TC, Zimmer SG: Inhibition of collagenolytic activity relates to quantitative reduction of invasion in vitro in a c-Ha-ras transfected glial cell line. J Neuro-oncol 21: 141-150, 1994
34. Hirvonen HE, Salonen R, Sandberg MM, Vuorio E, Västrik I, Kotilainen E, Kalimo H: Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines. Br J Cancer 69: 16-25, 1994
35. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994
36. DeClerck YA, Yean TD, Chan D, Shimada H, Langley KE: Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res 52: 2151-2157, 1992
37. Giese A, Rief MD, Loo MA, Berens ME: Determinants of human astrocytoma migration. Cancer Res 54: 3897-3904, 1994
38. Paulus W, Tonn JC: Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 80: 515-519, 1994
39. Merzak A, Koocheckpour S, Pilkington GJ: CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54: 3988-3992, 1994
40. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS: Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53: 4143-4147, 1993
41. Garbisa S, Scagliotti G, Masiero L, Di Francesco C, Caenazzo C, Onisto M, Micela M, Stetler-Stevenson WG, Liotta LA: Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res 52: 4548-4549, 1992
42. Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J: Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer 70: 506-512, 1994
43. Alvarez OA, Carmichael DF, DeClerck YA: Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinase. J Natl Cancer Inst 82: 585-595, 1990
44. Schultz RM, Silberman S, Persky G, Bajkowski AS, Carmichael DF: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48: 5539-5545, 1988
45. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR: A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53: 2087-2091, 1993
46. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R: Effects of inhibitors of plasminogen activator, serine proteases and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48: 3307-3312, 1988
47. Paganetti PA, Caroni P, Schwab ME: Glioblastoma infiltration into central nervous system tissue in vitro: Involvement of a metalloprotease. J Cell Biol 107: 2281-2291, 1988